Is There Evidence that Topical Formulations Can Support the Microbiome?
The Little Ones: Perspectives on Pediatric Psoriasis and AD
DermWireTV: Atopic Dermatitis Guidelines, Derm Devices, and New Research
Close Up With Lawrence Eichenfield, MD
FDA Approves Roflumilast for Seborrheic Dermatitis in Young Patients
Patrick Burnett, MD, PhD, FAAD, Chief Medical Officer
Loading...
Stay current with the best on medical education
We’re glad to see you’re enjoying PracticalDermatology…but how about a more personalized experience?
Press cancel to remain on PracticalDermatology. Press the link below or the continue button to keep going.